Credit Suisse Group AG CS has stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients, Reuters reported Wednesday, citing a cannabis company executive and other industry sources.
The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the United States.
While it's not yet clear what impact this decision will have, Reuters reported the move has affected the sale of marijuana stocks in recent weeks.
Abner Kurtin, CEO of cannabis company Ascend Wellness Holdings, Inc., said several "large investors in the space lost their ability to custodian the stocks,” and that the move resulted in a significant sell-off of cannabis stocks.
Reuters pointed out that the value of MSOS, a U.S.-listed cannabis exchange-traded fund, dropped over 20% since early February.
AdvisorShares launched AdvisorShares Pure US Cannabis ETF MSOS on Sept. 2, to track companies that generate at least half their revenue from the U.S. cannabis and hemp industries.
MSOS Price Action: MSOS shares traded down 1.78% to $41.96 Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.